Is Chandra Bhagat Pharma Ltd (542934) a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Chandra Bhagat Pharma Ltd is a below average quality company .

Is Chandra Bhagat Pharma Ltd (542934) undervalued or overvalued?

The key valuation ratios of Chandra Bhagat Pharma Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone .

What is Chandra Bhagat Pharma Ltd (542934) share price return in the past 10 years?

Data is not available for this company

Is Chandra Bhagat Pharma Ltd (542934) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Chandra Bhagat Pharma Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Chandra Bhagat Pharma Ltd (542934)?

Company share prices are keep on changing according to the market conditions. The current trading price of Chandra Bhagat Pharma Ltd (542934) on 17-Apr-2026 16:59:59 at 16:59 is 35.00.

What is the P/E ratio of Chandra Bhagat Pharma?

The latest standalone P/E ratio of Chandra Bhagat Pharma as of 17-Apr-2026 is 30.79.

What is the P/B ratio of Chandra Bhagat Pharma Ltd (542934)?

The latest standalone P/B ratio of Chandra Bhagat Pharma Ltd (542934) as of 17-Apr-2026 is 0.92.

What is the 52-week high and low of Chandra Bhagat Pharma Ltd (542934)?

The 52-week high of Chandra Bhagat Pharma Ltd (542934) is Rs. 61.50 and the 52-week low is Rs. 29.95.

Chandra Bhagat Pharma Ltd (542934) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Chandra Bhagat Pharma Ltd (542934)
Brand: Chandra Bhagat Pharma

Chandra Bhagat Pharma Ltd (542934) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Chandra Bhagat Pharma Ltd (542934)

BSE: 542934 NSE:

Key Metrics

Market Cap

₹26 Cr.

P/E Ratio

30.79

Price to Book (P/B)

0.92

Price to Sales (P/S)

0.30

EV/EBITDA

11.66

Return on Capital Employed (ROCE)

6.66%

Current Price

₹35

Return on Equity (ROE)

3.05%

Return on Assets (ROA)

0.84%

Operating Profit Margin

-1.7%

Net Profit Margin

0.99%

Gross Profit Margin

2.4%

Book Value per Share

₹37.9

Sales Growth (YoY)

-60.83%

Sales Growth (3 Years)

-2.68%

Operating Profit Growth (1 Year)

NA%

Operating Profit Growth (3 Years)

NAN%

Net Profit Growth (1 Year)

-43.79%

52-Week Low / High

₹30 / 62

Net Profit Growth (3 Years)

2.49%

Dividend Yield

0.00%

Promoter Holding

72.19%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Revenue growth of Chandra Bhagat Pharma Ltd?

Chandra Bhagat Pharma Ltd revenue growth is -60.8% for FY-2025 , which is below its 5 year CAGR of -1.6% , indicating slower growth.

Q.1 Promoter shareholding and pledge status of Chandra Bhagat Pharma Ltd?

Promoters hold 72.19% of the Chandra Bhagat Pharma Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Chandra Bhagat Pharma Ltd vs industry peers?

Chandra Bhagat Pharma Ltd revenue CAGR is -1.60% , compared to the industry median CAGR of 5.54% , indicating slower growth and losing its market share.

Q.1 Which industry/sub-sector does Chandra Bhagat Pharma Ltd belong to?

Chandra Bhagat Pharma Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.1 Stock return of Chandra Bhagat Pharma Ltd over the last decade?

Over the last 5 year(s), the stock has delivered a CAGR of -6.12% based on the current price.

DeciZen - make an informed investing decision on Chandra Bhagat Pharm

Based on:

Data

M-Cap below 100cr DeciZen not available

Chandra Bhagat Pharma stock performance

Key Ratios

Is Chandra Bhagat Pharma Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	12.6%	14.3%	17.6%	13.4%	7.2%	7.6%	8.8%	7.4%	8.2%	6.7%	-
Value Creation Index ⓘ	-0.1	0.0	0.3	0.0	-0.5	-0.5	-0.4	-0.5	-0.4	-0.5	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	79.8	89.8	97.1	106	94	70.7	94.1	120	221	86.7	87
Sales YoY Gr.	-	12.5%	8.1%	9.5%	-11.6%	-24.8%	33.1%	27.2%	85%	-60.8%	-
Adj EPS ⓘ	8.4	5	3.6	1.4	0.6	0.6	1.9	1.3	1.3	0.3	1.1
YoY Gr.	-	-39.8%	-29.4%	-61.4%	-58.4%	1.8%	231%	-34.4%	4%	-76.3%	-
BVPS (₹) ⓘ	161.5	22.2	23.8	24.9	32.2	32.5	33.7	34.1	36.7	37.9	37.9
Adj Net Profit ⓘ	0.4	1.7	1.2	0.7	0.4	0.4	1.5	1	1	0.2	1
Cash Flow from Ops. ⓘ	0	-9	-6.2	4.1	-7.4	8.3	12.4	5.3	6.2	-5.6	-
Debt/CF from Ops. ⓘ	0	-2.5	-3.5	7.7	-4	3.3	1.7	3.6	2.7	-3.7	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	0.9%	-1.6%	-2.7%	-60.8%
Adj EPS ⓘ	-30.7%	-11.5%	-45.6%	-76.3%
BVPSⓘ	-14.9%	3.3%	4%	3.3%
Share Price	-	-5.5%	-31.7%	-41.7%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	5.3	23.8	15	6.4	2.1	1.7	5.5	3.5	3.5	0.8	3
Op. Profit Mgn % ⓘ	5.4	6.5	5.1	4.4	3.5	5.7	3.9	2.7	-3.3	-1.7	NAN
Net Profit Mgn % ⓘ	0.4	1.9	1.2	0.7	0.5	0.6	1.5	0.8	0.5	0.3	1
Debt to Equity ⓘ	4.4	3	2.7	2.3	1.2	1.1	0.8	0.7	0.6	0.7	-
Working Cap Days ⓘ	172	181	198	227	289	360	256	177	119	399	0
Cash Conv. Cycle ⓘ	130	121	122	133	163	202	161	122	57	125	0

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	1.1	-
TTM Sales (₹ Cr.)	86.7	-
BVPS (₹) ⓘ	37.9	-
Reserves (₹ Cr.) ⓘ	22	-
P/BV ⓘ	0.92	-
PE ⓘ	30.79	-

From the Market
52 Week Low / High (₹)	29.95 / 61.50
All Time Low / High (₹)	29.95 / 160.00
Market Cap (₹ Cr.)	26.4
Equity (₹ Cr.)	7.6
Face Value (₹)	10
Industry PE ⓘ	42.1

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Chandra Bhagat Pharm - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	79.84	89.79	97.06	106.28	93.98	70.70	94.08	119.67	221.37	86.72
Operating Expenses ⓘ +	75.56	85.42	92.47	101.69	90.86	67.01	91.33	116.49	228.57	88.24
Manufacturing Costs	0.14	0.15	0.13	0.31	0.14	0.24	0.34	0.70	3.93	3.20
Material Costs	62.98	73.60	82.39	92.37	85.80	59.74	81.36	106.58	208.04	73.28
Employee Cost	7.31	5.64	5.02	4.53	2.25	1.85	1.52	1.32	2.18	2.03
Other Costs ⓘ	5.12	6.02	4.93	4.48	2.66	5.18	8.11	7.89	14.42	9.73
Operating Profit ⓘ	4.29	4.37	4.59	4.59	3.12	3.68	2.75	3.18	-7.20	-1.53
Operating Profit Margin (%)	5.4%	4.9%	4.7%	4.3%	3.3%	5.2%	2.9%	2.7%	-3.3%	-1.8%
Other Income ⓘ +	0.39	0.49	0.67	0.44	0.44	0.48	1.62	0.29	11.33	5.52
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	3.71	3.81	3.67	4.09	3.11	3.76	3.24	2.20	1.39	1.95
Depreciation ⓘ	0.24	0.14	0.06	0.05	0.03	0.12	0.04	0.11	0.49	0.88
Profit Before Tax ⓘ	0.72	0.91	1.53	0.89	0.42	0.28	1.10	1.16	2.26	1.17
Tax ⓘ	0.37	0.25	0.50	0.20	0.11	0.09	0.30	0.26	0.73	0.31
Profit After Tax	0.35	0.66	1.03	0.69	0.31	0.19	0.80	0.91	1.53	0.86
PAT Margin (%)	0.4%	0.7%	1.1%	0.7%	0.3%	0.3%	0.9%	0.8%	0.7%	1.0%
Adjusted EPS (₹)	1.1	2.0	3.1	1.3	0.4	0.3	1.1	1.2	2.0	1.1
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	6.75	7.41	8.44	14.45	25.69	25.88	26.68	27.48	29.01	29.97
Share Capital ⓘ	0.42	0.42	0.42	0.67	7.55	7.55	7.55	7.55	7.55	7.55
Reserves ⓘ	6.33	6.99	8.03	13.78	18.14	18.33	19.13	19.93	21.46	22.42
Debt +	29.58	20.50	21.75	27.78	27.50	25.09	19.81	17.67	15.47	20.34
Long Term Debt	0	4.22	11.74	11.46	10.89	9.45	5.42	3.93	1.41	2.28
Short Term Debt	29.58	16.28	10.01	16.32	16.62	15.63	14.39	13.74	14.06	18.05
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	5.66	16.27	15.48	29.70	12.49	12.85	2.67	3.10	13.23	8.95
Others Liabilities ⓘ	2.50	11.68	12.36	10.91	9.06	7.96	23.31	12.34	44.07	42.20
Total Liabilities ⓘ	44.49	55.87	58.04	82.84	74.74	71.78	72.46	60.58	101.78	101.46
Fixed Assets
Net Fixed Assets ⓘ +	0.69	0.55	0.51	0.46	0.44	0.42	0.47	0.73	2.52	2.62
Gross Block	0.69	0.70	1.23	1.24	1.24	1.26	1.13	1.50	3.78	4.25
Accumulated Depreciation	0	0.14	0.72	0.78	0.81	0.84	0.66	0.77	1.25	1.63
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investments ⓘ	0	4.64	1.05	4.03	0.75	0	0.22	0.11	0.13	0.14
Inventories	21.19	26.75	32.64	43.91	43.90	35.14	34.16	29.08	8.68	0.69
Trade Receivables	14.47	19.66	17.86	26.30	14.03	15.42	15	8.19	39.45	35.95
Cash Equivalents	4.68	0.58	0.55	0.48	0.05	2.82	5.68	6.44	4.96	0.67
Others Assets ⓘ	3.46	3.69	5.42	7.66	15.57	17.98	16.93	16.04	46.04	61.40
Total Assets ⓘ	44.49	55.87	58.04	82.84	74.74	71.78	72.46	60.58	101.78	101.46

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-9.03	-6.18	4.05	-7.41	8.33	12.40	5.26	6.18	-5.58
PBT ⓘ	0.91	1.53	0.89	0.42	0.28	1.10	1.16	2.26	1.17
Adjustment ⓘ	3.17	3.13	3.82	2.69	3.46	3.03	2.29	1.87	2.81
Changes in Working Capital ⓘ	-12.86	-10.55	-0.18	-10.53	4.68	8.38	2.14	2.5	-9
Tax Paid ⓘ	-0.25	-0.28	-0.47	0	-0.10	-0.11	-0.23	-0.46	-0.56
Cash Flow From Investing Activity ⓘ +	0.30	-0.36	-0.40	0.05	0.12	0.09	-0.06	-1.85	-1.23
Capex	-0	-0.02	-0.01	-0	-0.02	-0.09	-0.37	-2.28	-1.20
Net Investments	0	0	0	0	0	0	0	0	0
Others ⓘ	0.31	-0.34	-0.39	0.05	0.14	0.17	0.31	0.43	-0.03
Cash Flow From Financing Activity ⓘ +	7.97	6.51	-3.73	6.94	-6.42	-9.62	-4.45	-5.80	2.19
Net Proceeds from Shares ⓘ	0	0	5.30	10.93	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	11.31	9.67	-5.04	-0.93	-1.96	-5.30	-1.58	-4.41	0.58
Interest Paid ⓘ	-3.34	-3.16	-3.99	-3.06	-3.48	-3.08	-2.19	-1.39	-1.95
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0
Others ⓘ	-0	0	0	-0	-0.98	-1.25	-0.68	-0	3.56
Net Cash Flow ⓘ	-0.75	-0.02	-0.08	-0.43	2.02	2.86	0.76	-1.48	-4.62

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	5.38	9.33	13.44	6.46	1.67	0.78	3.19	3.54	5.73	3.05
ROCE (%)	12.62	14.34	17.58	13.4	7.16	7.63	8.83	7.37	8.22	6.66
Asset Turnover Ratio	1.84	1.79	1.7	1.51	1.19	0.96	1.3	1.8	2.73	0.85
PAT to CFO Conversion(x)	0	-13.68	-6	5.87	-23.9	43.84	15.5	5.78	4.04	-6.49
Working Capital Days
Receivable Days	60	69	71	76	78	76	59	35	39	159
Inventory Days	98	97	112	131	171	204	134	96	31	20
Payable Days	32	54	70	89	90	77	35	10	14	55

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Chandra Bhagat Pharma Ltd FAQs

The current trading price of Chandra Bhagat Pharm on 17-Apr-2026 16:59 is ₹35.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Apr-2026 the market cap of Chandra Bhagat Pharm stood at ₹26.41 Cr

The latest P/E ratio of Chandra Bhagat Pharm as of 16-Apr-2026 is 30.79.

The latest P/B ratio of Chandra Bhagat Pharm as of 16-Apr-2026 is 0.92.

The 52-week high of Chandra Bhagat Pharm is ₹61.50 and the 52-week low is ₹29.95.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Chandra Bhagat Pharm is ₹86.72 ( Cr.) .

About Chandra Bhagat Pharma Ltd

No data to display

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Chandra Bhagat Pharma Ltd (542934) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Chandra Bhagat Pharm Share Price